OraSure Technologies, Inc. (NASDAQ:OSUR) Short Interest Up 17.2% in January

OraSure Technologies, Inc. (NASDAQ:OSUR - Get Free Report) was the target of a significant increase in short interest in the month of January. As of January 31st, there was short interest totalling 1,910,000 shares, an increase of 17.2% from the January 15th total of 1,630,000 shares. Based on an average daily volume of 879,000 shares, the days-to-cover ratio is presently 2.2 days.

Wall Street Analysts Forecast Growth

Separately, StockNews.com cut shares of OraSure Technologies from a "buy" rating to a "hold" rating in a report on Thursday, February 13th.

OraSure Technologies Trading Down 1.5 %

OSUR traded down $0.06 during midday trading on Thursday, reaching $3.88. The company's stock had a trading volume of 706,914 shares, compared to its average volume of 803,773. The firm has a market capitalization of $289.42 million, a price-to-earnings ratio of 25.87 and a beta of 0.05. OraSure Technologies has a 1 year low of $3.52 and a 1 year high of $8.04. The stock's 50-day moving average is $3.81 and its 200-day moving average is $4.03.

Institutional Investors Weigh In On OraSure Technologies

A number of institutional investors have recently made changes to their positions in the company. Mackenzie Financial Corp grew its holdings in shares of OraSure Technologies by 229.4% during the fourth quarter. Mackenzie Financial Corp now owns 134,051 shares of the medical instruments supplier's stock valued at $484,000 after buying an additional 93,359 shares during the last quarter. Public Employees Retirement System of Ohio purchased a new stake in shares of OraSure Technologies during the fourth quarter valued at approximately $277,000. Two Sigma Advisers LP grew its holdings in shares of OraSure Technologies by 36.9% during the fourth quarter. Two Sigma Advisers LP now owns 97,200 shares of the medical instruments supplier's stock valued at $351,000 after buying an additional 26,200 shares during the last quarter. Two Sigma Investments LP purchased a new stake in shares of OraSure Technologies during the fourth quarter valued at approximately $552,000. Finally, Systematic Financial Management LP grew its holdings in shares of OraSure Technologies by 33.7% during the fourth quarter. Systematic Financial Management LP now owns 1,673,609 shares of the medical instruments supplier's stock valued at $6,042,000 after buying an additional 421,497 shares during the last quarter. Hedge funds and other institutional investors own 93.50% of the company's stock.

About OraSure Technologies

OraSure Technologies, Inc, together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company's products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D.